Table 1. Clinicopathological data of patients and tumours according to nuclear survivin expression.

	Patients		Nuclear survivin
	No.	%	Positive	%	P-value
Total	84		67	79.7
Male	60	71.4	50	74.6	0.198
Female	24	28.6	17	25.4
Age (years)
Median	56.8		56.5		0.557
Range	37–84
T-stage	84		67
T1+T2	34	40.5	24	35.8	0.134
T3+T4	50	59.5	43	64.2
Lymph node metastasis	83		67
Node negative	32	38.6	20	29.9	0.001
Node positive	51	61.4	47	70.1
Grading	79		63
G1+G2	35	44.3	29	46	0.54
emsp;G3	44	55.7	34	54
UICC-stage	84		67
I	8	9.5	4	6	0.006
II	23	27.4	15	22.4
III	37	44	32	47.8
IV	16	19	16	23.9